Glicla-Natrapharm

Glicla-Natrapharm

gliclazide

Manufacturer:

Natrapharm

Distributor:

Natrapharm
Concise Prescribing Info
Contents
Gliclazide
Indications/Uses
Dosage/Direction for Use
Initially 30 mg once daily. May be increased up to a max of 120 mg daily if necessary.
Administration
Should be taken with food.
Contraindications
Type 1 DM. Patients w/ ketoacidosis, severe infections, trauma or other severe conditions where drug is unlikely to control hyperglycemia. Severe hepatic & renal impairment. Porphyria. Pregnancy & lactation.
Special Precautions
Monitor blood glucose conc carefully in patients w/ renal impairment.
Adverse Reactions
GI disturbances eg, nausea, vomiting, heartburn, anorexia, diarrhea & metallic taste; increased appetite, wt gain; skin rashes, pruritus, photosensitivity.
MIMS Class
ATC Classification
A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Glicla-Natrapharm MR tab 30 mg
Packing/Price
15's;60's (P318.65/box)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in